RHDV2 Vaccine By Medgene Labs

Published by Michel T Kohl on

Medgene Labs, a vaccine and immunological services provider based in Brookings, SD, has received emergency use authorization for their experimental Rabbit Hemorrhagic Disease Virus 2 (RHDV2) vaccine from the USDA Center for Veterinary Biologics (CVB).

VaMedgene Labs is currently working with the USDA and state veterinarians to provide access to the vaccine nationwide. With Emergency Use Authorization, there are specific steps and documentation required to distribute the vaccine. The company is prepared to start receiving orders during the first week of October 2021 and has launched a web page to provide more information and answer frequently asked questions.

Specific information can be found here: https://medgenelabs.com/rhdv2-vaccine/

Categories: Other News


Leave a Reply

Avatar placeholder

Your email address will not be published. Required fields are marked *